Rituximab for the treatment of refractory pediatric autoimmune diseases: a case series

INTRODUCTION: To report on efficacy, tolerability and safety of rituximab in children with refractory autoimmune diseases. CASE PRESENTATION: Five patients (juvenile dermatomyositis, Wegener's granulomatosis, systemic lupus erythematosus, myasthenia gravis and multiple sclerosis with systemic l...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Asıl Yazarlar: Tzaribachev, Nikolay, Koetter, Ina, Kuemmerle-Deschner, Jasmin B, Schedel, Joerg
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: BioMed Central 2009
Konular:
Case report
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC2827140/
https://ncbi.nlm.nih.gov/pubmed/20184679
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4076/1757-1626-2-6609
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller